Xofigo
Active substance: radium ra-223 dichloride
INJECTION · RADIUM RA-223 DICHLORIDE 30 uCi/mL
United StatesActive
Marketing holder: Bayer HealthCare Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- RADIUM RA-223 DICHLORIDE · 30 uCi/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1209b-1023-76f0-9d29-2cfb64ba8459;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 50419-208
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 50419-208 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 50419-208 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 50419-208 · Verified 2026-10-09 · open in source